10885

    0

    JFLLIFE

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    JFL LIFE SCIENCES LIMITED Share Price Today

    JFL LIFE SCIENCES LIMITED is currently trading at ₹9.3, up by ₹0.3 from the previous close. The stock touched an intraday high of ₹9.30 and a low of ₹9.30 during the latest trading session. Over the past one year, JFL LIFE SCIENCES LIMITED has delivered a loss of 42.85%, while the stock has gained 0.0% in the last one month.

    JFL LIFE SCIENCES LIMITED performance

    Today’s low Today’s high
    ₹ 9.30 ₹ 9.30
    ₹ 9.00
    52 week low 52 week high
    ₹ 8.55 ₹ 16.85
    ₹ 9.00
    Open Price ₹ 9.30
    Prev. Close ₹ 9.00
    Volume (Shares) 18000.00
    Total traded value ₹ 1.62
    Upper Circuit ₹ 9.45
    Lower Circuit ₹ 8.55
    info

    Investment Returns

    Over 1 Month 0.00% Over 3 Months 5.26% Over 6 Months -25.49% Over 1 Year -42.85%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    JFL LIFE SCIENCES LIMITED fundamentals


    • Market cap (Cr) 29.70
    • P/E Ratio (TTM) 4.64
    • Beta 0.48
    • Book Value / share 13.90
    • Return on equity 11.09%
    • EPS (TTM) 1.94
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 1.66
    info icon alternate text
    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) [-]
    info icon alternate text

    JFL LIFE SCIENCES LIMITED Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 63.05
    Operating Expense 60.84
    Net Profit 1.66
    Net Profit Margin (%) 2.63
    Earnings Per Share (EPS) 0.50
    EBITDA 3.55
    Effective Tax Rate (%) 26.22
    Particulars DEC 2025 (Values in Cr)
    Revenue 26.84
    Operating Expense 24.14
    Net Profit 2.02
    Net Profit Margin (%) 7.52
    Earnings Per Share (EPS) 0.61
    EBITDA 3.36
    Effective Tax Rate (%) 25.46
    Particulars SEP 2025 (Values in Cr)
    Revenue 29.91
    Operating Expense 27.70
    Net Profit 1.97
    Net Profit Margin (%) 6.58
    Earnings Per Share (EPS) 0.60
    EBITDA 2.93
    Effective Tax Rate (%) 10.81
    Particulars JUN 2025 (Values in Cr)
    Revenue 11.59
    Operating Expense 10.16
    Net Profit 0.75
    Net Profit Margin (%) 6.47
    Earnings Per Share (EPS) 0.23
    EBITDA 1.93
    Effective Tax Rate (%) 47.55
    Particulars MAR 2025 (Values in Cr)
    Revenue 11.73
    Operating Expense 11.04
    Net Profit 0.08
    Net Profit Margin (%) 0.68
    Earnings Per Share (EPS) 0.03
    EBITDA 1.38
    Effective Tax Rate (%) 88.40
    Particulars MAR 2026 (Values in Cr)
    Revenue 131.38
    Operating Expense 122.86
    Net Profit 6.40
    Net Profit Margin (%) 4.87
    Earnings Per Share (EPS) 1.94
    EBITDA 11.79
    Effective Tax Rate (%) 25.58
    Particulars MAR 2025 (Values in Cr)
    Revenue 82.04
    Operating Expense 75.92
    Net Profit 4.16
    Net Profit Margin (%) 5.07
    Earnings Per Share (EPS) 1.26
    EBITDA 8.20
    Effective Tax Rate (%) 32.24
    Particulars MAR 2024 (Values in Cr)
    Revenue 46.55
    Operating Expense 43.26
    Net Profit 3.30
    Net Profit Margin (%) 7.08
    Earnings Per Share (EPS) 1.00
    EBITDA 5.09
    Effective Tax Rate (%) 12.92
    Particulars MAR 2023 (Values in Cr)
    Revenue 42.83
    Operating Expense 40.75
    Net Profit 2.81
    Net Profit Margin (%) 6.56
    Earnings Per Share (EPS) 2.90
    EBITDA 5.57
    Effective Tax Rate (%) 24.46
    Particulars MAR 2022 (Values in Cr)
    Revenue 33.59
    Operating Expense 30.68
    Net Profit 2.81
    Net Profit Margin (%) 8.36
    Earnings Per Share (EPS) 4.12
    EBITDA 6.25
    Effective Tax Rate (%) 26.05
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 11.96
    ROE % 11.09
    ROCE % 15.77
    Total Debt to Total Equity 0.22
    EBITDA Margin 10.01
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 32.35
    ROE % 9.73
    ROCE % 11.51
    Total Debt to Total Equity 0.19
    EBITDA Margin 10.96
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 29.34
    ROE % 12.90
    ROCE % 15.42
    Total Debt to Total Equity 0.53
    EBITDA Margin 12.98
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 14.08
    ROE % 30.93
    ROCE % 23.10
    Total Debt to Total Equity 1.80
    EBITDA Margin 18.61
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 138.28
    ROE % 8.82
    ROCE % 10.23
    Total Debt to Total Equity 2.13
    EBITDA Margin 6.87
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.06
    Total Assets 71.91
    Total Liabilities 71.91
    Total Equity 39.45
    Share Outstanding 3
    Price to Book Ratio 1.46
    Return on Assets (%) 5.78
    Return on Capital (%) 8.31
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.44
    Total Assets 56.71
    Total Liabilities 56.71
    Total Equity 35.57
    Share Outstanding 1
    Price to Book Ratio 1.22
    Return on Assets (%) 5.81
    Return on Capital (%) 8
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.06
    Total Assets 49.06
    Total Liabilities 49.06
    Total Equity 32.27
    Share Outstanding 1
    Price to Book Ratio 1.12
    Return on Assets (%) 5.72
    Return on Capital (%) 7.12
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.19
    Total Assets 48.26
    Total Liabilities 48.26
    Total Equity 11.29
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 5.82
    Return on Capital (%) 10.35
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.03
    Total Assets 29.00
    Total Liabilities 29.00
    Total Equity 6.87
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 1.86
    Return on Capital (%) 2.29
    Particulars MAR 2025 (Values in Cr)
    Net Income 6.13
    Cash from Operations -2.50
    Cash from Investing -0.01
    Cash from Financing 3.54
    Net change in Cash 0.00
    Free Cash Flow -2.11
    Particulars MAR 2024 (Values in Cr)
    Net Income 3.79
    Cash from Operations 8.41
    Cash from Investing -6.06
    Cash from Financing -2.31
    Net change in Cash -0.02
    Free Cash Flow 14.50
    Particulars MAR 2023 (Values in Cr)
    Net Income 3.71
    Cash from Operations -8.07
    Cash from Investing 0.87
    Cash from Financing 8.07
    Net change in Cash -0.12
    Free Cash Flow -8.07
    Particulars MAR 2022 (Values in Cr)
    Net Income 3.80
    Cash from Operations 2.19
    Cash from Investing -0.71
    Cash from Financing -1.46
    Net change in Cash 0.15
    Free Cash Flow 3.88
    Particulars MAR 2021 (Values in Cr)
    Net Income 0.74
    Cash from Operations -5.77
    Cash from Investing -1.64
    Cash from Financing 7.24
    Net change in Cash -0.26
    Free Cash Flow -4.05
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.08 12.84 1.50 238.18 23.12 38.85
    BLISS GVS PHARMA LTD 530.35 43.05 4.71 5624.69 118.35 541.75
    CIPLA LTD 1453.50 30.85 3.41 117420.32 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 356.70 15.73 2.58 1049.80 256.40 399.00
    GLAXOSMITHKLINE PHARMACEUTICAL 2354.65 41.46 17.59 39889.19 2088.00 3460.80
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.08 21.73 4.00 238.18 23.12 38.85
    AMRUTAJAN HEALTH LTD 539.05 24.16 4.20 1558.43 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8054.15 105.19 23.07 20135.38 7630.00 9850.00
    BLISS GVS PHARMA LTD 530.35 57.21 4.86 5624.69 118.35 541.75

    JFL LIFE SCIENCES LIMITED shareholding pattern

    Holding
    32.53%
    67.46%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    JFL LIFE SCIENCES LIMITED Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    9.00 0.00 redarrow
    red-green-graph indicator
    16 Bearish
    0 Bullish
    • 5 Days 9.10
    • 26 Days 9.40
    • 10 Days 9.30
    • 50 Days 9.50
    • 12 Days 9.30
    • 100 Days 10.30
    • 20 Days 9.40
    • 200 Days 11.70
    9.03 PIVOT
    First Support 8.97 First Resistance 9.07 Second Support 8.93 Second Resistance 9.13 Third Support 8.87 Third Resistance 9.17
    RSI 43.60 ADX 26.39 MACD -0.08 Williams % R -100.00 Commodity Channel Index (CCI) -73.39
    Date 2026-06-29 Week 16000.00 Same Day 18000.00 Month 17200.00
    1 Year 0.49 3 Year 0.40
    Over 1 Month
    0.00% down
    Over 1 Year
    -42.85% down
    Over 3 Months
    5.26% down
    Over 3 Years
    -10.91% down
    Over 6 Months
    -25.49% down
    Over 5 Years
    0.00% down

    JFL LIFE SCIENCES LIMITED Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    13 Sep 2024 0.25 Final 16 Sep 2024 Equity shares
    Ex-Date Ex-Bonus Ratio
    24 Sep 2024 24 Sep 2024 2:1

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of JFL Life Sciences Ltd?

    Answer Field

    JFL Life Sciences Ltd share price is for NSE ₹ 9.30 & for BSE ₹ 0.00 as on Jul 01 2026 01:59 PM.

    What is the Market Cap of JFL Life Sciences Ltd Share?

    Answer Field

    The market cap of JFL Life Sciences Ltd for NSE ₹ 29.70 & for BSE ₹ 0.00 as on Jul 01 2026 01:59 PM.

    What is the 52 Week High and Low of JFL Life Sciences Ltd?

    Answer Field

    The 52 Week High and Low of JFL Life Sciences Ltd for NSE is ₹ 16.85 and ₹ 8.55 and for BSE is ₹ 0.00 and ₹ 0.00.

    What is 1 year return for JFL Life Sciences Ltd?

    Answer Field

    The 1 year returns on the stock has been -42.85%.

    What is the P/E Ratio of JFL Life Sciences Ltd Share?

    Answer Field

    As on Jul 01 2026 01:59 PM the price-to-earnings (PE) ratio for JFL Life Sciences Ltd share is 4.64.

    What is the PB ratio of JFL Life Sciences Ltd Share?

    Answer Field

    As on Jul 01 2026 01:59 PM, the price-to-book (PB) ratio for JFL Life Sciences Ltd share is 13.90.

    How to Buy JFL Life Sciences Ltd Share?

    Answer Field

    You can trade in JFL Life Sciences Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy JFL Life Sciences Ltd Share on Bajaj Broking App?

    Answer Field

    To buy JFL Life Sciences Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “JFL Life Sciences Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |